Prothena Corp Public (PRTA) Treasury Shares (2022 - 2026)
Prothena Corp Public (PRTA) recorded quarterly Treasury Shares of $1.6 million in Q1 2026, up 42.22% quarter-over-quarter from $1.1 million in Q4 2025, and up 433.98% on a YoY basis from $290509.0 in Q1 2025.
Prothena Corp Public (PRTA) Treasury Shares (2022 - 2026) Analysis & Trends
Prothena Corp Public's Treasury Shares history runs 5 years deep, the most recent figure standing at $1.6 million for Q1 2026.
- In Q1 2026, Treasury Shares rose 433.98% year-over-year to $1.6 million; the TTM figure through Mar 2026 stood at $1.6 million (up 433.98% YoY), while the FY2025 annual figure was $1.1 million, up 18079.63% from the prior year.
- Treasury Shares was $1.6 million for Q1 2026 at Prothena Corp Public, up from $1.1 million in the prior quarter.
- In the past five years, Treasury Shares ranged from a high of $1.6 million in Q1 2026 to a low of $6000.0 in Q4 2024.
- Historically, Treasury Shares has averaged $325042.7 across 5 years, with a median of $25250.0 in 2023.
- The sharpest annual moves came in 2024 and 2025: Treasury Shares tumbled 76.24% in 2024, then jumped 18079.63% in 2025.
- A 5-year view of Treasury Shares shows it stood at $23000.0 in 2022, then increased by 9.78% to $25250.0 in 2023, then sank by 76.24% to $6000.0 in 2024, then surged by 18079.63% to $1.1 million in 2025, then jumped by 42.22% to $1.6 million in 2026.
- The last three Treasury Shares figures came in at $1.6 million (Q1 2026), $1.1 million (Q4 2025), and $1.1 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 1.48 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 700,000.00 |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Prothena Corp Public | 479.08 Mn | 149.61 Mn | - | 1.55 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.55 Mn |
| Mar 31, 2026 | 1.55 Mn |
| Dec 31, 2025 | 1.09 Mn |
| Dec 31, 2025 | 1.09 Mn |
| Sep 30, 2025 | 1.13 Mn |
| Sep 30, 2025 | 1.13 Mn |
| Jun 30, 2025 | 283,307.00 |
| Jun 30, 2025 | 283,307.00 |
| Mar 31, 2025 | 290,509.00 |
| Mar 31, 2025 | 290,509.00 |
| Dec 31, 2024 | 6,000.00 |
| Dec 31, 2024 | 6,000.00 |
| Sep 30, 2024 | 24,250.00 |
| Sep 30, 2024 | 24,250.00 |
| Jun 30, 2024 | 25,250.00 |
| Jun 30, 2024 | 25,250.00 |
| Mar 31, 2024 | 25,250.00 |
| Mar 31, 2024 | 25,250.00 |
| Dec 31, 2023 | 25,250.00 |
| Dec 31, 2023 | 25,250.00 |